Kosan Biosciences kosan.com


is developing two new classes of anticancer agents: heat shock protein 90 (Hsp90) inhibitors and epothilones. Hsp90 inhibitors target multiple pathways involved in cancer cell growth and survival and have the potential to overcome resistance after relapse and to synergize the initial activity of existing cancer therapies. Kosan's epothilone program is partnered with Roche through a global development and commercialization agreement.

is developing two new classes of anticancer agents: heat shock protein 90 (Hsp90) inhibitors and epothilones. Hsp90 inhibitors target multiple pathways involved in cancer cell growth and survival and have the potential to overcome resistance after re...Show all

Company (Acquired)

Phone: 510-732-8400

Fax:

3832 Bay Center Place

Hayward, 94545
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kosan Biosciences $46.3M Apr 13, 2001

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kosan Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Canaan PartnersVenture CapitalMenlo Park, California, United StatesOther Investors
Alta PartnersVenture CapitalSan Francisco, California, United StatesSeries C, Series B
Franklin Templeton InvestmentsAsset/Investment ManagementToronto, Ontario, CanadaSeries C
AG Biotech CapitalSeries C, Series B
Franklin AdvisersSeries C
See all 14 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Intermediates and methods for the preparation of epothilones Nov 12, 2008 Apr 02, 2013 Patent
Process for the preparation of epothilones May 09, 2008 Oct 04, 2011 Patent
Methods of making epothilones May 09, 2008 Jun 07, 2011 Patent
Macrolactams by engineered biosynthesis Jan 23, 2008 Dec 21, 2010 Patent
Biosynthetic gene cluster for leptomycins Aug 24, 2007 Dec 14, 2010 Patent
See all 12 patents